XDR-TB


Also found in: Dictionary, Acronyms, Wikipedia.

XDR-TB

abbr.
extensively drug-resistant tuberculosis

XDR-TB

extensively drug-resistant tuberculosis.
Mentioned in ?
References in periodicals archive ?
Spoligotyping revealed that 90% of the XDR-TB patients were infected with a genetically similar strain, Dr.
Initial data from the study shows the promise of BPaL to treat XDR-TB in only 6 months - Bedaquiline (400 mg daily for 2 weeks followed by 200 mg twice a week), Pretomanid (200 mg daily) and Linezolid (1200 mg daily) given orally for 6 months with the option to extend treatment to 9 months for participants who do not culture convert within 4 months.
In standard precaution practices, all patients with MDR-TB and XDR-TB were using the mask and sputum bin; but, in TB wards, around 30% of patients with TB were using sputum bin and mask.
The principles of MDR-TB and XDR-TB treatment are shown in Table 3.
According to latest estimates, 996 of 17,615 MDR-TB cases in South Africa were identified as XDR-TB, representing some 5.6% of all MDR-TB cases.
The 49 XDR-TB cases were reported from nine states and one city, with the largest numbers in New York City (19 cases) and California (11 cases) (Figure).
As if this was not enough, after 3 months of treatment, he was told in January 2014 that his MDR-TB had escalated to extremely drug resistant TB (XDR-TB).
[1] South Africa (SA) has reported some of the highest numbers of DR-TB cases globally: in 2012 alone there were 14 161 laboratory-notified cases of multidrug-resistant TB (MDR-TB) and 1 545 cases of extensively drug-resistant TB (XDR-TB).
Multi Drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are emerging as a major challenges across globe including in India as narrated by the World Health Organization (WHO) for success the Stop TB strategy, launched in 2006.
Using the definition of extreme drug resistant TB (XDR-TB) i.e.
Washington, May 11 (ANI): Belgian physicians using a novel two-drug combination developed by researchers at Albert Einstein College of Medicine of Yeshiva University have cured a young patient with extensively drug-resistant tuberculosis (XDR-TB).
The paper by Sharma and colleagues (1) on the prevalence of extensively drug-resistant tuberculosis (XDR-TB)in a hospital study is an important contribution to India's TB control programme.